Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 307

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 307
---
  Less: imputed interest                                        ( 2,553  
  Present value of lease liabilities      $                       6,975  

NOTE 6:- OTHER PAYABLES AND ACCRUED EXPENSES

                                      December 31,                                  
                                      2023                         2024             
 ────────────────────────────────────────────────────────────────────────────────────
  Employees and payroll accruals      $                 1,159      $         1,400  
  Accrued expenses                                      2,236                2,615  
  Related parties                                          79                  118  
                                      $                 3,474      $         4,133  

F-19

ALPHA TAU
MEDICAL LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 7:
- LONG-TERM LOAN

In connection with financing the acquisition
of a long-term leasehold on a plot of land in the Har Hotzvim Industrial Park in Jerusalem, the Company entered into agreements with Bank
Leumi Le-Israel BM (the “ Lender”), for: 1) a letter of credit in the amount of approximately NIS7,904($2,054) to the benefit
of the Israel Land Authority in September 2023, and 2) a long-term loan in the amount of approximately NIS20,263($5,248) in October
2023. Both instruments are denominated in NIS and secured by deposits that the Company maintains at the Lender.

Following an extension of the long-term
loan agreed with the Lender, the long-term loan matures in a bullet payment due in October 2026, subject to any extensions as may be agreed
with the Lender, and bears monthly interest at a spread of0.46% below the NIS prime rate in Israel, which is1.50% above the Bank of
Israel lending rate.

The Company chose to use these financing
instruments to close the acquisition of the long-term leasehold, pending its exploration of comprehensive long-term financing alternatives
for the development of the land into a larger headquarters for the Company.

For the year ended December 31, 2023,
the Company recorded interest expenses and currency exchange expenses in amount of $75and $338, respectively.

For the year ended December 31, 2024,
the Company recorded interest expenses and currency exchange